Linezolid Sandoz

Linezolid, the active ingredient in Linezolid Sandoz, is an oxazolidinone presented as an injectable solution for intravenous use. It treats serious Gram‑positive bacterial infections, including skin and soft‑tissue infections, community‑acquired and hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA).

GNH USA supplies Linezolid Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to manage serious bacterial infections.

- Skin and soft tissue infections: provides clinical cure against Gram‑positive pathogens, including MRSA. - Community‑acquired bacterial pneumonia: eradicates susceptible Streptococcus pneumoniae and other causative organisms. - Hospital‑acquired (nosocomial) pneumonia: effective for resistant strains in intensive‑care settings. - MRSA infections: offers a treatment option for infections resistant to beta‑lactams and other classes.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal discomfort. - Diarrhea: loose stools, often self‑limiting. - Headache: mild to moderate intensity. - Metallic taste: transient alteration of taste perception. - Thrombocytopenia: mild reduction in platelet count. - Elevated liver enzymes: mild, reversible increase.

Serious or Rare Side Effects: - Myelosuppression: severe anemia, leukopenia, or pancytopenia requiring monitoring. - Serotonin syndrome: risk when combined with serotonergic agents. - Peripheral neuropathy: sensory changes with prolonged therapy. - Lactic acidosis: rare metabolic disturbance. - Severe hypersensitivity: rash, angioedema, or anaphylaxis. - Vision changes: optic neuropathy with long‑term use.

Before initiating Linezolid therapy, consider patient‑specific factors and monitor appropriately.

- Renal impairment: assess renal function and monitor for accumulation. - Hepatic impairment: evaluate liver enzymes and adjust monitoring. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Myelosuppression: perform baseline and periodic complete blood counts. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity. - Rifampicin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, monitor INR. - Theophylline: possible increase in serum levels, watch for toxicity. - NSAIDs: may augment bleeding risk, especially with thrombocytopenia.